Rogers Erica J. 4
4 · Silk Road Medical Inc · Filed Jun 13, 2023
Insider Transaction Report
Form 4
Rogers Erica J.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2023-06-12$32.13/sh−1,000$32,130→ 269,639 total - Exercise/Conversion
Common Stock
2023-06-12$1.60/sh+1,000$1,600→ 270,639 total - Award
Common Stock
2023-05-19$26.17/sh+507$13,268→ 269,639 total - Exercise/Conversion
Option (right to buy)
2023-06-12−1,000→ 14,654 totalExercise: $1.60From: 2016-09-04Exp: 2026-08-04→ Common Stock (1,000 underlying)
Holdings
- 83,843(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c).
- [F2]The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on August 8, 2022, prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
- [F3]These shares are held directly by Kevin J. Surace and Erica J. Rogers, as Trustees of The Surace Rogers Family Trust.
- [F4]All of the shares subject to the option are fully vested and exercisable as of the date hereof.